{"retracted":false,"update":{"timestamp":1483228800000,"doi":"10.1016/j.jhep.2016.10.020","type":"erratum"},"doi":"10.1016/s0168-8278(16)01707-4","journal":"Journal of Hepatology","publisher":"Elsevier BV","title":"Retraction notice to: PS124â€“Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199]"}
